Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

NCT06951737 is registered in ClinicalTrials.gov with Bursa Postgraduate Hospital as lead sponsor.

NCT NCT06951737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06951737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients
Lead sponsor
Bursa Postgraduate Hospital
Phase
Observational
Overall status
Completed
Start date
October 2, 2022
Completion date
October 2, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), diabetes mellitus